DrugPatentWatch Database Preview
Drugs in Development Information for ETX2514
Email this page to a colleague
What is the drug development status for ETX2514?
ETX2514 is an investigational drug.
There have been 7 clinical trials for ETX2514.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 29th 2019.
The most common disease conditions in clinical trials are Infection, Communicable Diseases, and Pneumonia, Bacterial. The leading clinical trial sponsors are Entasis Therapeutics, Clinartis, and [disabled in preview].
There are two US patents protecting this investigational drug and forty-two international patents.
Summary for ETX2514
| US Patents | 2 |
| International Patents | 42 |
| US Patent Applications | 2 |
| WIPO Patent Applications | 1 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2019-03-29) |
| Vendors | 4 |
Recent Clinical Trials for ETX2514
| Title | Sponsor | Phase |
|---|---|---|
| Study to Determine the Excretion and Metabolism of 14C-ETX2514 Administered Intravenously in Healthy Male Subjects | Entasis Therapeutics | Phase 1 |
| Study Evaluating the Effect of ETX2514 on Cardiac Repolarization in Healthy Male or Female Volunteers | Entasis Therapeutics | Phase 1 |
| Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex | Entasis Therapeutics | Phase 3 |
Clinical Trial Summary for ETX2514
Top disease conditions for ETX2514
Top clinical trial sponsors for ETX2514
US Patents for ETX2514
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| ETX2514 | Try Before You Buy | Beta-lactamase inhibitor compounds | Entasis Therapeutics Limited (London, GB) | Try Before You Buy |
| ETX2514 | Try Before You Buy | .beta.-lactamase inhibitor compounds | Entasis Therapeutics Limited (London, GB) | Try Before You Buy |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for ETX2514
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| ETX2514 | Argentina | AR090539 | 2032-04-02 | Try Before You Buy |
| ETX2514 | Australia | AU2013245399 | 2032-04-02 | Try Before You Buy |
| ETX2514 | Canada | CA2866467 | 2032-04-02 | Try Before You Buy |
| ETX2514 | Chile | CL2014002589 | 2032-04-02 | Try Before You Buy |
| ETX2514 | China | CN104364254 | 2032-04-02 | Try Before You Buy |
| ETX2514 | Colombia | CO7071137 | 2032-04-02 | Try Before You Buy |
| ETX2514 | Costa Rica | CR20140428 | 2032-04-02 | Try Before You Buy |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
